Exercise Intervention for Multiple Sclerosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a phone app can help people with multiple sclerosis (MS) become more active. Participants will either maintain their usual routine or use the ExerciseRx app, an exercise intervention, to track and increase their daily steps and weekly exercise goals. The app aims to boost activity levels through personalized goals and support messages. Individuals with MS who currently exercise less than 150 minutes per week and can walk unaided might be a good fit for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance daily life for those with MS.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on increasing physical activity for people with multiple sclerosis.
What prior data suggests that this app-based exercise intervention is safe for individuals with multiple sclerosis?
Research has shown that exercise programs for people with multiple sclerosis (MS) are generally safe. Studies have found that exercise does not increase the risk of MS flare-ups and is an effective way to aid recovery. Current evidence supports that exercise is not only safe but also beneficial for those with MS.
Participants using the ExerciseRx app receive support to meet personalized daily step targets and weekly goals. This method was tested and found safe for increasing physical activity in adults with MS. Overall, exercise programs like this are well-tolerated and do not pose significant safety concerns.12345Why are researchers excited about this trial?
Unlike traditional treatments for multiple sclerosis (MS) that often focus on medications to manage symptoms, the ExerciseRx intervention is all about personalized physical activity. Researchers are excited because it uses an app to tailor daily step goals and weekly targets based on individual progress, making it a highly customized approach. This method encourages engagement through feedback and support from providers, which could lead to better adherence and outcomes. It's a novel way of integrating technology with personal health goals, offering a fresh perspective in managing MS through lifestyle changes rather than just medication.
What evidence suggests that the ExerciseRx intervention is effective for increasing physical activity in multiple sclerosis patients?
Research shows that exercise programs are safe and effective for enhancing physical abilities in people with multiple sclerosis (MS). Studies indicate that exercise can lead to lasting improvements in both physical and social activities for those with MS. Evidence suggests that different exercise plans can help in various ways, depending on individual goals. In this trial, participants in the ExerciseRx-MS arm will use the ExerciseRx app to reach personal activity targets and encourage more physical activity. With support from healthcare providers, this approach may help people with MS start and maintain regular exercise habits. Meanwhile, participants in the usual care arm will receive MS Exercise and Physical Activity Recommendations and continue their typical physical activity.12346
Who Is on the Research Team?
Dawn Ehde, PhD
Principal Investigator
UW Medicine
Are You a Good Fit for This Trial?
This trial is for adults over 18 with Multiple Sclerosis who can walk without help but are not very active (less than 150 minutes of exercise per week). They must have an iPhone or Android phone to use the study app and cannot be at high risk of falling or have other conditions that make exercising unsafe.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the ExerciseRx app to meet personalized daily step targets and weekly goals, with provider support and monitoring.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at weeks 13 and 26.
What Are the Treatments Tested in This Trial?
Interventions
- ExerciseRx intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor